Status:
UNKNOWN
Predicting Adjuvant Post-operative Radiation Therapy in Patients With Cervical Cancer Stage IB2
Lead Sponsor:
Kaplan Medical Center
Collaborating Sponsors:
Barzilai Medical Center
Hillel Yaffe Medical Center
Conditions:
Cancer of the Cervix
Conization of the Cervix
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
A pre- operative evaluation for the presence of intermediate risk factors prior to surgery may allow for better patient counselling, modify the course of surgery or select patients to undergo primary ...
Detailed Description
Patients with cervical cancer who are scheduled for radical hysterectomy and underwent a pre- operative MRI and PET- CT that have demonstrated a tumor ≥2- 4cm cm and the absence of nodal metastasis on...
Eligibility Criteria
Inclusion
- Patients with cervical cancer who are scheduled for radical hysterectomy and underwent a pre- operative imaging (MRI and PET CT) that have demonstrated a tumor ≥2-4 cm and the absence of nodal metastasis.
- Pre -operative assessment by the surgeon that a large loop biopsy of depth of 1.5 and a diameter of 1 cm is technically feasible.
- Patient who in the course of the preoperative evaluation underwent large loop biopsy of depth of 1.5 and a diameter of 1.0 cm, and in the subsequent evaluation fulfilled the criteria in (1).
- Exclusion Criteria:
- Patient who do not sign the informed consent. Patient who is scheduled for Chemoradiation Patients with large loop biopsy which is smaller than depth of 1.5 and a diameter of 1.0 cm
Exclusion
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04868097
Start Date
April 1 2021
End Date
March 31 2023
Last Update
April 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaplan Medical Center
Rehovot, Israel, 76100